Global Epigenetics Market Trends, Analysis, Growth, and Forecast: 2018 to 2027

MarketResearch.biz delivers in-depth insights on the global epigenetics market in its upcoming report titled, “Global Epigenetics Market Trends, Applications, Analysis, Growth, and Forecast: 2018 to 2027”. The global epigenetics market is estimated to register a CAGR of X.X% in terms of value during forecast period 2018–2027. The report offers in-depth insights, revenue details, and other vital information regarding the target market, and the various trends, drivers, restraints, opportunities, and threats till 2027. The report offers insightful and detailed information regarding the various key players operating in the market, their financials, supply chain trends, technological innovations, key developments, apart from future strategies, acquisitions & mergers, and market footprint. The global epigenetics market report has been segmented on the basis of product, technology, application, end user and region.

Epigenetics includes process that alter gene activities. Epigenetics processes are natural and essential to many organism functions, however, if they occur improperly they may cause adverse behavioral and health effects. Epigenetics involves modifications or activation of certain genes but does not involve change in basic structure of DNA. Epigenetics changes are influenced by various factors, such as age, environment, surrounding, lifestyle, disease state, and others. The study of epigenetics mechanism and DNA methylation have gained importance in many research fields which includes developmental biology, cancer research, DNA repair, identification of biomarkers, potential drug targets.

Increasing in number of research activities for epigenetics owing to its wide applications in research field is expected to drive the global epigenetics market over the forecast period. In addition, increasing government funding for epigenetics research is expected to propel the market growth over the forecast period. Furthermore, rising prevalence of cancer and others disease globally is other factor which in turn is expected to create demand for global epigenetics market.

However, high costs of instruments and lack of skilled personnel are major factors expected to restrain the global epigenetics market growth over the forecast period.

North America market dominates the global epigenetics market in terms of revenue contribution as compared to that of markets in other regions. This is attributed to the developed healthcare infrastructure, high adoption of advance technologies, increasing incidence of cancer and other diseases, and favorable government funding in the region. Europe accounts for second-largest revenue share contribution to the global epigenetics market, followed by markets in the Asia Pacific, Latin America, and the Middle East & Africa respectively. The market in the Asia Pacific is projected to register comparatively faster growth in terms of revenue over the next 10 years. This is attributed owing to increasing number of research institutes, rising prevalence of cancer and other diseases, and rising healthcare expenditure in the region.

Global epigenetics market segmentation, by product:

• Reagents
• Kits
• Instruments
• Enzymes

Global epigenetics market segmentation, by technology:

• DNA Methylation
• Histone Modifications
• RNA-Associated Silencing

Global epigenetics market segmentation, by application:

• Oncology
  • Solid Tumors
  • Liquid Tumors
• Non Oncology
  • Cardiovascular diseases
  • Infectious diseases
  • Inflammatory disease
  • Metabolic diseases

Global epigenetics market segmentation, by end user:

• Academic and Research Institutes
• Pharmaceutical and Biotechnology Companies
• Contract Research Organizations

 Global epigenetics market segmentation, by region:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

• Bio-Rad Laboratories, Inc.
• Thermo Fisher Scientific Inc.
• Diagenode
• QIAGEN
• Abcam Plc.
• New England Biolabs
• Agilent Technologies
• Zymo Research
• PerkinElmer, Inc.
• Active Motif